Vladimir Rafalskiy

460 total citations
30 papers, 233 citations indexed

About

Vladimir Rafalskiy is a scholar working on Molecular Biology, Epidemiology and Biophysics. According to data from OpenAlex, Vladimir Rafalskiy has authored 30 papers receiving a total of 233 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Epidemiology and 6 papers in Biophysics. Recurrent topics in Vladimir Rafalskiy's work include Spectroscopy Techniques in Biomedical and Chemical Research (6 papers), Urinary Tract Infections Management (4 papers) and Antiplatelet Therapy and Cardiovascular Diseases (3 papers). Vladimir Rafalskiy is often cited by papers focused on Spectroscopy Techniques in Biomedical and Chemical Research (6 papers), Urinary Tract Infections Management (4 papers) and Antiplatelet Therapy and Cardiovascular Diseases (3 papers). Vladimir Rafalskiy collaborates with scholars based in Russia, Spain and United States. Vladimir Rafalskiy's co-authors include Ronald Kalmeijer, Graham R. Foster, Ira M. Jacobson, Michael Fried, Oliver Lenz, Sivi Ouwerkerk‐Mahadevan, Maria Beumont‐Mauviel, Marc Peeters, Antonio Craxı̀ and Л. В. Мороз and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Vladimir Rafalskiy

19 papers receiving 219 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vladimir Rafalskiy Russia 7 116 83 47 32 21 30 233
Antoine Laudat France 7 187 1.6× 166 2.0× 56 1.2× 34 1.1× 25 1.2× 14 361
Luís Bento Portugal 10 87 0.8× 15 0.2× 4 0.1× 29 0.9× 26 1.2× 45 238
Francis Seow Australia 9 67 0.6× 48 0.6× 8 0.2× 26 0.8× 27 1.3× 13 318
Shamardan Ezzeldin S. Bazeed Egypt 8 76 0.7× 28 0.3× 29 0.6× 9 0.3× 95 4.5× 20 260
Emanuela Messina Italy 10 116 1.0× 104 1.3× 9 0.2× 23 0.7× 75 3.6× 37 224
Dimitrios S. Karagiannakis Greece 10 236 2.0× 231 2.8× 21 0.4× 29 0.9× 10 0.5× 38 347
Simona Coladonato Italy 6 73 0.6× 23 0.3× 8 0.2× 61 1.9× 91 4.3× 11 202
Patricio Ibáñez Chile 9 130 1.1× 17 0.2× 16 0.3× 15 0.5× 33 1.6× 42 218
Wynton Hoover United States 8 30 0.3× 9 0.1× 27 0.6× 37 1.2× 38 1.8× 11 166
Marcela Peña‐Rodríguez Mexico 10 88 0.8× 39 0.5× 14 0.3× 145 4.5× 115 5.5× 24 297

Countries citing papers authored by Vladimir Rafalskiy

Since Specialization
Citations

This map shows the geographic impact of Vladimir Rafalskiy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vladimir Rafalskiy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vladimir Rafalskiy more than expected).

Fields of papers citing papers by Vladimir Rafalskiy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vladimir Rafalskiy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vladimir Rafalskiy. The network helps show where Vladimir Rafalskiy may publish in the future.

Co-authorship network of co-authors of Vladimir Rafalskiy

This figure shows the co-authorship network connecting the top 25 collaborators of Vladimir Rafalskiy. A scholar is included among the top collaborators of Vladimir Rafalskiy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vladimir Rafalskiy. Vladimir Rafalskiy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zyubin, Andrey, et al.. (2025). Sers-based methodology for nanomolar methotrexate concentration detection for clinics. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 331. 125801–125801. 3 indexed citations
2.
Rafalskiy, Vladimir, et al.. (2024). Enhancing the Efficacy and Safety of Methotrexate Treatment: A Focus on Drug Interactions (Review). SHILAP Revista de lepidopterología. 12(3). 285–298.
3.
Rafalskiy, Vladimir, et al.. (2024). Real-world data for monitoring antimicrobial resistance to urinary tract infection pathogens. SHILAP Revista de lepidopterología. 4(3). 22–32.
4.
Rafalskiy, Vladimir, et al.. (2024). Cardiovascular events in patients with psoriasis and psoriatic arthritis treated with JAK/TYK inhibitors: A systematic review and meta‐analysis. Journal of the European Academy of Dermatology and Venereology. 39(5). e430–e435. 1 indexed citations
5.
Zyubin, Andrey, et al.. (2023). Mathematical Analysis of Raman Spectra Data Arrays Using Machine Learning Algorithms. Journal of Biomedical Photonics & Engineering. 20308–20308. 1 indexed citations
6.
Газатова, Н. Д., et al.. (2023). Dynamics of endothelial function indexes in patients with post-Covid syndrome using a combination drug of ethylmethylhydroxyperidine succinate/vitamin B6. Research Results in Pharmacology. 9(2). 21–26. 2 indexed citations
7.
Rafalskiy, Vladimir, et al.. (2023). JAK-inhibitors: clinical pharmacology and application perspectives. Reviews on Clinical Pharmacology and Drug Therapy. 20(4). 421–434. 1 indexed citations
8.
Cardoso, Rhanderson, et al.. (2023). 1704-P: Efficacy and Safety of Tirzepatide for Weight Loss—A Meta-analysis of Randomized Controlled Trials. Diabetes. 72(Supplement_1). 1 indexed citations
9.
Rafalskiy, Vladimir, et al.. (2023). Surface-enhanced Raman spectroscopy for searching pharmacodynamic predictors of response to antiplatelet therapy. Siberian Journal of Clinical and Experimental Medicine. 38(3). 185–193.
10.
Zyubin, Andrey, et al.. (2022). Spectral homogeneity of human platelets investigated by SERS. PLoS ONE. 17(5). e0265247–e0265247. 4 indexed citations
11.
Rafalskiy, Vladimir, et al.. (2022). Application of vibrational spectroscopy and nuclear magnetic resonance methods for drugs pharmacokinetics research. Drug Metabolism and Personalized Therapy. 38(1). 3–13. 1 indexed citations
14.
Rafalskiy, Vladimir, et al.. (2021). NMR spectroscopy reveals acetylsalicylic acid metabolites in the human urine for drug compliance monitoring. PLoS ONE. 16(3). e0247102–e0247102. 3 indexed citations
15.
Zyubin, Andrey, et al.. (2021). Spectral and time-resolved photoluminescence of human platelets doped with platinum nanoparticles. PLoS ONE. 16(9). e0256621–e0256621.
16.
Zyubin, Andrey, et al.. (2020). Surface-enhanced Raman spectroscopy for antiplatelet therapy effectiveness assessment. Laser Physics Letters. 17(4). 45601–45601. 20 indexed citations
17.
Zyubin, Andrey, et al.. (2020). Dataset of human platelets in healthy and individuals with cardiovascular pathology obtained by surface-enhanced Raman spectroscopy. SHILAP Revista de lepidopterología. 29. 105145–105145. 6 indexed citations
19.
Rafalskiy, Vladimir, et al.. (2017). Resistance of urinary tract pathogens and the choice of antimicrobial therapy: deceptive simplicity. Urologiia. 3_2017(3). 104–110.
20.
Дедов, И. И., et al.. (2016). Assessing routine healthcare pattern for type 2 diabetes mellitus in Russia: the results of рharmacoepidemiological study (FORSIGHT-DM2). Diabetes Mellitus. 19(6). 443–456. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026